Pathos AI, Inc. News

Pathos AI raises $237M to scale Foundry and advance four oncology assets

New York-based Pathos AI closed a $237 million Series E led by Bristol Myers Squibb, with participation from existing investors. The financing values the company at approximately $3 billion after the...